Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading

By person

22 insiders · 141 transactions

0.9×

Yuval Cohen holds only 0.9 times base salary in stock. $645.09K of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $4.10, the price Common Stock was last bought or sold at on the open market here, on 29 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cormorant Asset Management, LP entity

Former 10% Owner

$53.69M (31)

$2.09M (2)

+$51.61M

4,264,942

22.05%

$17.49M

+53.0%

Yuval Cohen

Chief Executive Officer

$122.23K (15)

$3.76M (13) scheduled

−$3.64M

157,316

0.8134%

$645.09K

—

Sean F. Moran

Chief Financial Officer

$144.20K (12)

$1.54M (11) scheduled

−$1.40M

84,694

0.4379%

$347.30K

—

David P Hochman

Director

$269.18K (7)

—

+$269.18K

814,400

4.21%

$3.34M

+5.9%

Barbara White

Chief Medical Officer

$254.36K (12)

—

+$254.36K

206,217

1.07%

$845.61K

+28.0%

Nishant C Saxena

Chief Business Officer

$126.25K (3)

—

+$126.25K

77,900

0.4028%

$319.44K

+2,126%

Dominic Smethurst

Chief Medical Officer

—

$120.51K (3)

−$120.51K

89,790

0.4642%

$368.19K

—

Robert Paul Discordia

Chief Operating Officer

$109.51K (3)

—

+$109.51K

35,490

0.1835%

$145.53K

+134.3%

Paris Panayiotopoulos

Director

$100.39K (1)

—

+$100.39K

14,285

0.0739%

$58.58K

—

Craig Stuart Millian

Chief Operating Officer

$76.55K (8)

—

+$76.55K

27,000

0.1396%

$110.72K

—

John Kenneth Jenkins

Director

$6.98K (1)

$58.45K (2) scheduled

−$51.47K

3,833

0.0198%

$15.72K

—

Anne Altmeyer

Director

—

$50.91K (3) scheduled

−$50.91K

7,579

0.0392%

$31.08K

—

Avery W Catlin

Director

$45.84K (2)

—

+$45.84K

4,350

0.0225%

$17.84K

—

Ian Hodgson

Chief Operating Officer

—

$25.79K (2)

−$25.79K

51,080

0.2641%

$209.46K

+96.6%

Winston Kung

Director

—

$16.03K (1) scheduled

−$16.03K

12,140

0.0628%

$49.78K

—

Yong Ben

Director

—

$15.68K (1) scheduled

−$15.68K

9,383

0.0485%

$38.48K

—

Alan F Holmer

Director

$10.61K (2)

—

+$10.61K

10,629

0.0550%

$43.59K

—

Mark Tepper

President and CSO

—

2,110,400

10.91%

$8.65M

+0.5%

Leonardo Viana Nicacio

Chief Medical Officer

—

58,333

0.3016%

$239.20K

—

Rachelle Suzanne Jacques

Director

—

11,383

0.0589%

$46.68K

—

Brent Pfeiffenberger

Director

—

7,500

0.0388%

$30.75K

—

Peter Salzmann

Director

—

2,783

0.0144%

$11.41K

—

Corbus Pharmaceuticals Holdings, Inc.

What the insiders did Net buying

By person